Synthia Gets a Shotgun - Goodbye genetic engineering?
Submitted by Jim Thomas on
What do ocean-going yachts, space-traveling bacteria and synthetic life have in common? J. Craig Venter, of course. The self-styled genome tycoon has been busy pushing the boundaries on what may appear at first glance to be unrelated enterprises. Nothing could be further from the truth. A suite of recently uncovered patent applications lodged by Venter and his colleagues reveal not only an attempt to grab ownership over much of synthetic biology (see news release) but also a breathtakingly bold business plan for producing millions of new synthetic organisms per day. At the heart of this are plans for a new, automated process enabling rapid assembly of complete synthetic genomes - plans that, if realised, could render current genetic engineering techniques quaint and obsolete. Venter calls it "homologous in vitro recombination" or "combinatorial genomics." ETC suggests it might be properly dubbed "shotgun synthesis" and it has the potential to blast apart current biotech practice.